Skip to content

Rejuvatek Medical

1 viewer · 30d

Total raised

$500K

+$500K this year

1 filing since 2026 · latest Equity filed

Cumulative raised
LAST ROUND
Equity · $500K
ROUNDS
1
INVESTORS
1
FOUNDED
N/A
HQ
Sandy, UT
SECTOR
Healthcare
EMPLOYEES
N/A
30D VIEWERS
1

AI overview

Updated

Rejuvatek Medical is a Sandy, Utah medical aesthetics company that develops non-laser tattoo and permanent makeup removal technology. Its flagship system, inkOUT, uses patented TEPR (Trans-Epidermal Pigment Release) technology: controlled dermabrasion disrupts the ink, and a solution called TEPRsol drives the pigment out through the surface of the skin as it heals rather than into the body. The company sells through a network of certified providers such as med spas, dermatology practices and aesthetic centers, and appointed board-certified dermatologist Dr. Stephen Eubanks as medical director for the inkOUT portfolio.

What sets it apart

Removes ink outward through the epidermis instead of breaking it down for the lymphatic system to absorb, which the company says works on every ink color — including yellow, white and pastels that lasers struggle with — and across all Fitzpatrick skin types.

Funding history

1 round
EquityFeb 10, 2026 · $50K min
Form D
+$500K$500K total

Latest SEC filings

via EDGAR · CIK 0001781709
Form D · Feb 10, 2026View on EDGAR

Products

1 tracked

inkOUT

Aesthetic medical device and treatment system

A non-laser tattoo and permanent makeup removal system built on patented TEPR (Trans-Epidermal Pigment Release) technology, delivered at certified provider clinics over a course of treatments.

  • Patented TEPR (Trans-Epidermal Pigment Release) process
  • TEPRsol solution paired with controlled dermabrasion
  • Effective on all ink colors including yellow, red, white, blue, pastel and neon
  • Suitable for all Fitzpatrick skin types I-VI